Skip to content

Search

Case Study: Eppendorf

An online ordering system from Eppendorf, one of The Kids Research Institute Australia’s laboratory equipment and consumables Supply Partners, is proving to be a winner.

Case Study: NEC

NEC Australia has joined forces with The Kids Research Institute Australia to ensure a state-of-the-art ICT system is in place at the new Perth Children’s Hospital.

Schools

Tailored to spark curiosity and link directly to the Australian curriculum, our schools program engages young minds and bridges the gap between classroom learning and cutting-edge medical research.

Home School Inquiry Form

Everything you need to know to book a home schooler excursion at the The Kids Discovery Centre.

Discover Series: Cancer

What would you discover to help a child? At The Kids, our researchers are committed to Cancer research that makes a real difference.

Fearless Xander: Why we research children's cancers

Ten-year-old Xander has been through more than most kids of his age – specifically, three-and-a-half years of gruelling chemotherapy to treat leukaemia.

The Power of Why

Our job is to find the answers. It's helping us change kids' lives. See the "why?"s we're asking and answering.

A diagnostic test for acute rheumatic fever (pilot study)

Currently there are no diagnostic tests for ARF, and no treatments targeting immune responses to improve disease outcomes.

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)

The MELODY Study is a Phase 3 randomized, double-blind, placebo-controlled, single-dose study to determine if MEDI8897 will prevent medically attended Respiratory Syncytial Virus (RSV) -confirmed Lower Respiratory Tract Infection (LRTI) in healthy infants entering their first RSV season.